Host Cell Protein Testing Market to reach USD 4.34 billion by 2032 and grow at a CAGR of 8.14%.
The global host cell protein (HCP) testing market will grow enormously during the forecast period. The factors driving the same include rising demand for biologics and biosimilars with rising chronic diseases, improvements in HCP testing technology, and accelerated adoption in the drug development process. The leading companies are actively investing in R&D and developing innovative solutions, which will further fuel the growth trajectory in this market.